Skip to content

Insider · CIK 0001374150

DOMAIN PARTERS VII L P

Reports to the SEC for 11 companies · PRINCETON, NJ

Transactions

50

Companies

11

Filings

10

CIK

0001374150

Forms 4 and 5

Insider transactions

50 trades
DateCompanyValue
2019-08-06HINDVyome Holdings, Inc · Warrants to Purchase Common StockP Purchase+$750K
2019-08-06HINDVyome Holdings, IncP Purchase+$1M
2018-08-23HINDVyome Holdings, IncP Purchase+$3M
2016-11-01Tobira Therapeutics, Inc.U Disposition from Tender−$101M
2016-10-12HINDVyome Holdings, Inc · Series B Preferred StockC Conversion—
2016-10-12HINDVyome Holdings, IncC Conversion—
2016-10-12HINDVyome Holdings, Inc · Series D Preferred StockC Conversion—
2016-10-12HINDVyome Holdings, Inc · Series E Preferred StockC Conversion—
2016-10-12HINDVyome Holdings, Inc · Series C Preferred StockC Conversion—
2016-10-12HINDVyome Holdings, Inc · Series A Preferred StockC Conversion—
2016-05-26EVOKEvoke Pharma IncS Sale−$1.62M
2016-04-27EVOKEvoke Pharma IncS Sale−$18.1K
2016-04-25EVOKEvoke Pharma IncS Sale−$7,758.4
2016-04-20EVOKEvoke Pharma IncS Sale−$23.4K
2016-04-19EVOKEvoke Pharma IncS Sale−$199K
2016-04-11EVOKEvoke Pharma IncS Sale−$22.7K
2016-04-08EVOKEvoke Pharma IncS Sale−$77.9K
2016-04-07EVOKEvoke Pharma IncS Sale−$146K
2016-04-06EVOKEvoke Pharma IncS Sale−$45.3K
2015-08-18EVOKEvoke Pharma IncS Sale−$83.1K
2015-05-04Tobira Therapeutics, Inc.P Purchase+$2.95M
2015-04-16EVOKEvoke Pharma IncS Sale−$229K
2015-04-15EVOKEvoke Pharma IncS Sale−$60K
2015-04-14EVOKEvoke Pharma IncS Sale−$76.5K
2015-03-20ESPREsperion Therapeutics, Inc.J Other—
2014-11-25EVFMEvofem Biosciences, Inc.F Tax Payment−$1.42M
2014-11-25EVFMEvofem Biosciences, Inc.M Exercise/Conversion+$1.42M
2014-11-25EVFMEvofem Biosciences, Inc.F Tax Payment−$787K
2014-11-25EVFMEvofem Biosciences, Inc. · Series C Preferred Stock Warrant (Right to Buy)M Exercise/Conversion—
2014-11-25EVFMEvofem Biosciences, Inc.P Purchase+$980K
2014-11-25EVFMEvofem Biosciences, Inc. · Series B-2 Preferred Stock Warrant (Right to Buy)M Exercise/Conversion—
2014-11-25EVFMEvofem Biosciences, Inc.M Exercise/Conversion+$787K
2014-11-25EVFMEvofem Biosciences, Inc.C Conversion—
2014-11-25EVFMEvofem Biosciences, Inc. · Series B-2 Preferred StockC Conversion—
2014-11-25EVFMEvofem Biosciences, Inc. · Series B Preferred StockC Conversion—
2014-11-25EVFMEvofem Biosciences, Inc. · Series A Preferred StockC Conversion—
2014-11-25EVFMEvofem Biosciences, Inc.F Tax Payment−$1.42M
2014-11-25EVFMEvofem Biosciences, Inc.M Exercise/Conversion+$1.42M
2014-11-25EVFMEvofem Biosciences, Inc.F Tax Payment−$787K
2014-11-25EVFMEvofem Biosciences, Inc.M Exercise/Conversion+$787K
2014-11-25EVFMEvofem Biosciences, Inc.C Conversion—
2014-11-25EVFMEvofem Biosciences, Inc.P Purchase+$980K
2014-11-25EVFMEvofem Biosciences, Inc. · Series C Preferred Stock Warrant (Right to Buy)M Exercise/Conversion—
2014-11-25EVFMEvofem Biosciences, Inc. · Series B-2 Preferred Stock Warrant (Right to Buy)M Exercise/Conversion—
2014-11-25EVFMEvofem Biosciences, Inc. · Series C Preferred StockC Conversion—
2014-11-25EVFMEvofem Biosciences, Inc. · Series C Preferred StockC Conversion—
2014-11-25EVFMEvofem Biosciences, Inc. · Series B-2 Preferred StockC Conversion—
2014-11-25EVFMEvofem Biosciences, Inc. · Series B Preferred StockC Conversion—
2014-11-25EVFMEvofem Biosciences, Inc. · Series A Preferred StockC Conversion—
2014-10-21ESPREsperion Therapeutics, Inc.P Purchase+$10M